PT728147E - Peptideos natriureticos auriculares especificos dereceptor - Google Patents

Peptideos natriureticos auriculares especificos dereceptor

Info

Publication number: PT728147E
Authority: PT; Portugal
Prior art keywords: human; receptor; dereceptor; headphones; peptide specific
Prior art date: 1993-11-12

Application number

PT95901112T

Other languages

English (en)

Inventor

Robert S Mcdowell

David Lowe

Brian C Cunningham

David Oare

John Burnier

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-11-12

Filing date

1994-11-04

Publication date

2003-06-30

1994-11-04 Application filed by Genentech Inc filed Critical Genentech Inc

2003-06-30 Publication of PT728147E publication Critical patent/PT728147E/pt

Links

235000016709 nutrition Nutrition 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1
239000002934 diuretic Substances 0.000 abstract 2
208000009304 Acute Kidney Injury Diseases 0.000 abstract 1
102000002723 Atrial Natriuretic Factor Human genes 0.000 abstract 1
101800001288 Atrial natriuretic factor Proteins 0.000 abstract 1
101800001890 Atrial natriuretic peptide Proteins 0.000 abstract 1
206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
206010019280 Heart failures Diseases 0.000 abstract 1
208000033626 Renal failure acute Diseases 0.000 abstract 1
201000011040 acute kidney failure Diseases 0.000 abstract 1
NSQLIUXCMFBZME-MPVJKSABSA-N carperitide Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 NSQLIUXCMFBZME-MPVJKSABSA-N 0.000 abstract 1
230000003247 decreasing effect Effects 0.000 abstract 1
230000001882 diuretic effect Effects 0.000 abstract 1
230000002503 metabolic effect Effects 0.000 abstract 1
230000001452 natriuretic effect Effects 0.000 abstract 1
102000005962 receptors Human genes 0.000 abstract 1
206010038464 renal hypertension Diseases 0.000 abstract 1
102220005466 rs35816645 Human genes 0.000 abstract 1
238000006467 substitution reaction Methods 0.000 abstract 1
230000002883 vasorelaxation effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Cardiology (AREA)
Gastroenterology & Hepatology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Toxicology (AREA)
Zoology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

PT95901112T 1993-11-12 1994-11-04 Peptideos natriureticos auriculares especificos dereceptor PT728147E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US15299493A	1993-11-12	1993-11-12

Publications (1)

Publication Number	Publication Date
PT728147E true PT728147E (pt)	2003-06-30

Family

ID=22545344

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT95901112T PT728147E (pt)	1993-11-12	1994-11-04	Peptideos natriureticos auriculares especificos dereceptor

Country Status (10)

Country	Link
EP (1)	EP0728147B1 (pt)
JP (1)	JP3989535B2 (pt)
AT (1)	ATE232545T1 (pt)
AU (1)	AU1934995A (pt)
CA (1)	CA2174517C (pt)
DE (1)	DE69432123T2 (pt)
DK (1)	DK0728147T3 (pt)
ES (1)	ES2194895T3 (pt)
PT (1)	PT728147E (pt)
WO (1)	WO1995013296A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6028055A (en) *	1996-10-22	2000-02-22	Genetech, Inc.	Receptor selective BNP
AU4816497A (en) *	1996-10-22	1998-05-15	Genentech Inc.	Receptor specific brain natriuretic peptide (bnp)
AU6820898A (en) *	1997-04-04	1998-10-30	Novo Nordisk A/S	Natriuretic peptide derivatives
US6013630A (en)	1997-08-21	2000-01-11	Curagen Corporation	Atrial natriuretic factor mutants and ischemic stroke
PL2348114T3 (pl)	2004-04-21	2019-08-30	Alexion Pharmaceuticals, Inc.	Koniugaty do dostarczania do kości i sposób ich wykorzystania do nakierowywania białek na kość
EP2004633A4 (en)	2006-03-30	2009-08-26	Palatin Technologies Inc	LINEAR NATRIURETIC PEPTIDE CONSTRUCTS
US8580746B2 (en)	2006-03-30	2013-11-12	Palatin Technologies, Inc.	Amide linkage cyclic natriuretic peptide constructs
KR101434612B1 (ko)	2006-03-30	2014-08-26	팔라틴 테크놀로지스 인코포레이티드	사이클릭 나트륨 이뇨 펩타이드 구조물
EP2658979B1 (en)	2010-12-27	2018-02-14	Alexion Pharmaceuticals, Inc.	Compositions comprising natriuretic peptides and methods of use thereof
US10052366B2 (en)	2012-05-21	2018-08-21	Alexion Pharmaceuticsl, Inc.	Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
US10822596B2 (en)	2014-07-11	2020-11-03	Alexion Pharmaceuticals, Inc.	Compositions and methods for treating craniosynostosis
MX389350B (es)	2014-12-05	2025-03-19	Alexion Pharma Inc	Fosfatasas alcalinas recombinantes y usos de las mismas para el tratamiento de convulsiones.
US10603361B2 (en)	2015-01-28	2020-03-31	Alexion Pharmaceuticals, Inc.	Methods of treating a subject with an alkaline phosphatase deficiency
KR102644116B1 (ko)	2015-08-17	2024-03-05	알렉시온 파마슈티칼스, 인코포레이티드	알칼린 포스파타제의 제조
WO2017058822A1 (en)	2015-09-28	2017-04-06	Alexion Pharmaceuticals, Inc.	Identifying effective dosage regimens for tissue non-specific alkaline phosphatase (tnsalp)-enzyme replacement therapy of hypophosphatasia
JP2018533571A (ja)	2015-10-30	2018-11-15	アレクシオンファーマシューティカルズ，インコーポレイテッド	患者の頭蓋縫合早期癒合症を治療するための方法
WO2017155569A1 (en)	2016-03-08	2017-09-14	Alexion Pharmaceuticals, Inc.	Methods for treating hypophosphatasia in children
CA3019726A1 (en)	2016-04-01	2017-10-05	Alexion Pharmaceuticals, Inc.	Treating muscle weakness with alkaline phosphatases
EP3436020A4 (en)	2016-04-01	2019-12-25	Alexion Pharmaceuticals, Inc.	METHOD FOR TREATING HYPOPHOSPHATASIE IN TEENS AND ADULTS
EP3464573A4 (en)	2016-06-06	2020-02-19	Alexion Pharmaceuticals, Inc.	EFFECTS OF METALS ON THE PRODUCTION OF ALKALINE PHOSPHATASES
WO2018035420A1 (en)	2016-08-18	2018-02-22	Alexion Pharmaceuticals, Inc.	Methods for treating tracheobronchomalacia
JP2020512363A (ja)	2017-03-31	2020-04-23	アレクシオンファーマシューティカルズ，インコーポレイテッド	成人及び青年における低ホスファターゼ症（ｈｐｐ）を治療する方法
US11913039B2 (en)	2018-03-30	2024-02-27	Alexion Pharmaceuticals, Inc.	Method for producing recombinant alkaline phosphatase
US12268733B2 (en)	2018-08-10	2025-04-08	Alexion Pharmaceuticals, Inc.	Methods of treating neurofibromatosis type 1 and related conditions with alkaline phosphatase
JP2023504208A (ja)	2019-12-09	2023-02-01	アレクシオンファーマシューティカルズ，インコーポレイテッド	アルカリホスファターゼポリペプチド及びその使用方法
US12083169B2 (en)	2021-02-12	2024-09-10	Alexion Pharmaceuticals, Inc.	Alkaline phosphatase polypeptides and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU4211989A (en) *	1988-08-18	1990-03-23	California Biotechnology, Inc.	Atrial natriuretic peptide clearance inhibitors
EP0465097A3 (en) *	1990-06-26	1993-03-24	Merck & Co. Inc.	Peptides having atrial natriuretic factor activity

1994
- 1994-11-04 WO PCT/US1994/012591 patent/WO1995013296A1/en not_active Ceased
- 1994-11-04 AT AT95901112T patent/ATE232545T1/de active
- 1994-11-04 ES ES95901112T patent/ES2194895T3/es not_active Expired - Lifetime
- 1994-11-04 DK DK95901112T patent/DK0728147T3/da active
- 1994-11-04 EP EP95901112A patent/EP0728147B1/en not_active Expired - Lifetime
- 1994-11-04 JP JP51387895A patent/JP3989535B2/ja not_active Expired - Fee Related
- 1994-11-04 CA CA002174517A patent/CA2174517C/en not_active Expired - Lifetime
- 1994-11-04 DE DE69432123T patent/DE69432123T2/de not_active Expired - Lifetime
- 1994-11-04 AU AU19349/95A patent/AU1934995A/en not_active Abandoned
- 1994-11-04 PT PT95901112T patent/PT728147E/pt unknown

Also Published As

Publication number	Publication date
DE69432123T2 (de)	2004-01-08
JPH09505049A (ja)	1997-05-20
WO1995013296A1 (en)	1995-05-18
AU1934995A (en)	1995-05-29
ES2194895T3 (es)	2003-12-01
EP0728147A1 (en)	1996-08-28
CA2174517A1 (en)	1995-05-18
CA2174517C (en)	2007-01-02
JP3989535B2 (ja)	2007-10-10
DK0728147T3 (da)	2003-06-10
ATE232545T1 (de)	2003-02-15
DE69432123D1 (de)	2003-03-20
EP0728147B1 (en)	2003-02-12

Publication	Publication Date	Title
PT728147E (pt)	2003-06-30	Peptideos natriureticos auriculares especificos dereceptor
FR2697525B1 (fr)	1997-04-04	Peptides de fusion ayant une activité de liaison à la streptavidine.
ATE322871T1 (de)	2006-04-15	Niedrig- profil selbst-expandierbarer blutgefäss stent
EP0637656A3 (en)	1995-03-08	Truss.
EP0663216A3 (en)	1995-09-13	Pump segment with connected, parallel branch line.
TR199600246A2 (tr)	1996-10-21	Frenlemeli protez mafsal.
NO883731L (no)	1989-08-21	Isbrytende skip.
EP0769554A3 (en)	1997-05-28	Human CNP gene and precursor protein
FI952217A7 (fi)	1996-02-13	Verisuoniproteesi, johon on imeytetty hepariinia sisältävä kollageenitiiviste
AU7321498A (en)	1998-06-29	Bit-interleaved rate16/17 modulation code with three-way byte-interleaved ECC
EP0605653A4 (en)	1995-03-15	NEW LIPOSACCHARID BINDING PROTEIN (LBP).
EP0651099A3 (en)	1996-04-24	Connector for truss.
DE69705658D1 (de)	2001-08-23	Modularer Aufbau, bestehend aus mehreren Einheiten, mit den entsprechenden Steckverbindern
DE68903836D1 (de)	1993-01-28	Verbrauchereinheiten.
DE68907830D1 (de)	1993-09-02	Mit tritium markierte verbindung, ihre herstellung und verwendung, besonders bei der bestimmung der affinitaet der retinoide fuer ihre nuklearen rezeptoren und ihr zytosol-bindendes protein.
AU2442084A (en)	1984-09-06	Two member boost stage valve
ID21765A (id)	1999-07-22	Atrial natriuretik peptide (anp) sebagai aditif pada larutan peritoneal dialisis
EP0609292A4 (en)	1995-10-25	Soluble variants of type i membrane proteins, and methods of using them.
DE58903291D1 (de)	1993-02-25	Biocompatible dialysemembran aus einem gemischten polysaccharidester.
AU2406684A (en)	1984-08-23	Hexanor-brassinolidine-22-ethers, i.e. 6-or7-oxa-b- homosteroids
NO974713L (no)	1997-10-10	Gener som koder for lymfocyttinterferon-regulatorisk faktor (LSIRF) polypeptider
DK44288D0 (da)	1988-01-29	Transportoer, isaer til tunge genstande
TR199902605T2 (xx)	2000-02-21	Fibrinojenin azalt�lma y�ntemleri.
DK0753512T3 (da)	1998-10-19	N,N-diethyl-8,8-dipropyl-2-azaspiro[4,5]decan-2-propanamin-dimaleat
FI893211A0 (fi)	1989-06-30	Antihypertensiva, n-terminala eteraminodiolamino-syraderivat.